Vestal Point Capital, LP - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Vestal Point Capital, LP held in its portfolio 76 assets valued at $2,941,274,351 (i.e. $2.94B).
The most valuable assets in the portfolio included: Abivax SA ($256.22M), Invesco QQQ Trust Series 1 ($215.01M), and Arcellx Inc ($190.71M).
The chart below shows the top 10 valuable assets, and the table below shows the top 76 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Vestal Point Capital, LP - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| Abivax SA | 1900000 | 256224500 | SPONSORED ADS |
| Invesco QQQ Trust Series 1 | 350000 | 215008500 | UNIT SER 1 |
| Arcellx Inc | 2925000 | 190710000 | COMMON STOCK |
| Terns Pharmaceuticals Inc | 4500000 | 181800000 | COM |
| BioMarin Pharmaceutical Inc | 3000000 | 178290000 | COM |
| Globus Medical Inc | 1275000 | 111320250 | CL A |
| Nurix Therapeutics Inc | 4690000 | 88969300 | COM |
| Alcon AG | 1105000 | 87085050 | ORD SHS |
| Dexcom Inc | 1275000 | 84621750 | COM |
| Merck & Co Inc | 775000 | 81576500 | COM |
| Taysha Gene Therapies Inc | 13750000 | 75625000 | COM SHS |
| Abbott Laboratories | 600000 | 75174000 | COM |
| Immatics NV | 6125000 | 64312500 | SHS |
| Tyra Biosciences Inc | 2425000 | 63753250 | COM |
| Bicara Therapeutics Inc | 3575000 | 60167250 | COM |
| Arrowhead Pharmaceuticals Inc | 900000 | 59751000 | COM |
| Enliven Therapeutics Inc | 3830000 | 58982000 | COM |
| Disc Medicine Inc | 735000 | 58366350 | COM |
| Jazz Pharmaceuticals PLC | 290000 | 49300000 | SHS USD |
| Day One Biopharmaceuticals Inc | 5200000 | 48464000 | COM |
| Lexeo Therapeutics Inc | 4475000 | 44436750 | COM |
| Alto Neuroscience Inc | 2485000 | 44233000 | COM SHS |
| Apogee Therapeutics Inc | 550000 | 41514000 | COM |
| Olema Pharmaceuticals Inc | 1650000 | 41250000 | COM |
| Axsome Therapeutics Inc | 210000 | 38354400 | COM |
| Ascendis Pharma A/S | 175000 | 37317000 | SPONSORED ADR |
| Rapport Therapeutics Inc | 1110000 | 33677400 | COM |
| Solid Biosciences Inc | 5815000 | 32796600 | COM NEW |
| Celldex Therapeutics Inc | 1165000 | 31641400 | COM NEW |
| Scholar Rock Holding Corp | 700000 | 30835000 | COM |
| KalVista Pharmaceuticals Inc | 1890000 | 30523500 | COM |
| Vera Therapeutics Inc | 550000 | 27852000 | CL A |
| Xenon Pharmaceuticals Inc | 600000 | 26892000 | COM |
| Lantheus Holdings Inc | 360000 | 23958000 | COM |
| Revolution Medicines Inc | 295000 | 23496750 | COM |
| Zymeworks Inc | 865000 | 22775450 | COM |
| Immunocore Holdings PLC | 585000 | 20305350 | ADS |
| Upstream Bio Inc | 720000 | 19548000 | COM |
| Beta Bionics Inc | 600000 | 18282000 | COM |
| Crescent Biopharma Inc | 1500000 | 17790000 | COM |
| BioCryst Pharmaceuticals Inc | 2250000 | 17550000 | COM |
| Penumbra Inc | 50000 | 15545500 | COM |
| Geron Corp | 11320000 | 14942400 | COM |
| Repligen Corp | 83000 | 13600380 | COM |
| Zimmer Biomet Holdings Inc | 150000 | 13488000 | COM |
| Bristol-Myers Squibb Co | 250000 | 13485000 | COM |
| Monte Rosa Therapeutics Inc | 775000 | 12152000 | COM |
| Fulcrum Therapeutics Inc | 950000 | 10744500 | COM |
| Savara Inc | 1606000 | 9684180 | COM |
| Engene Holdings Inc | 1055000 | 9526650 | COM |
| Agios Pharmaceuticals Inc | 325000 | 8846500 | COM |
| Definium Therapeutics Inc | 637000 | 8529430 | COM NEW |
| Denali Therapeutics Inc | 465000 | 7677150 | COM |
| Myriad Genetics Inc | 1223000 | 7521450 | COM |
| Tectonic Therapeutic Inc | 328000 | 6842080 | COM |
| Novocure Ltd | 525000 | 6788250 | ORD SHS |
| MapLight Therapeutics Inc | 385000 | 6762525 | COM |
| Gilead Sciences Inc | 50000 | 6137000 | COM |
| Voyager Therapeutics Inc | 1475000 | 5796750 | COM |
| DBV Technologies SA | 300000 | 5751000 | SPONSORED ADS |
| Mirum Pharmaceuticals Inc | 66000 | 5213340 | COM |
| Nyxoah SA | 1107000 | 5092200 | SHS |
| Nuvalent Inc | 46000 | 4627140 | COM |
| LENZ Therapeutics Inc | 275000 | 4400000 | COM |
| Rezolute Inc | 1686000 | 3978960 | COM NEW |
| Passage Bio Inc | 305000 | 3599000 | COM NEW |
| Sutro Biopharma Inc | 243000 | 2811510 | COM SHS |
| Structure Therapeutics Inc | 35000 | 2434250 | SPONSORED ADS |
| Dyne Therapeutics Inc | 120000 | 2347200 | COM |
| Black Diamond Therapeutics Inc | 870000 | 2114100 | COM |
| OnKure Therapeutics Inc | 635000 | 1841500 | COM CL A |
| Fate Therapeutics Inc | 1725000 | 1694985 | COM |
| Alector Inc | 755000 | 1177800 | COM |
| Tenax Therapeutics Inc | 53439 | 651421 | COM NEW |
| REGENXBIO Inc | 34000 | 489600 | COM |
| MacroGenics Inc | 280000 | 450800 | COM |